Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,480,097
-$16,247,905 QoQ
Shares Held
47,026
-33.2% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
#112
of 870 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tri Locum Partners LP holds $50,782,866 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (50.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
47,026 | $25,480,097 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
746,835 | $25,302,769 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,480,097 | 47,026 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,728,002 | 70,370 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $58,918,757 | 120,921 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $51,222,012 | 122,187 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $19,682,732 | 54,926 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,959,355 | 50,100 | Shares | Sole | 2024-08-14 | |
| 2021-12-31 | $9,918,936 | 45,904 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,063,637 | 32,851 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||